Tofranil, Base
Brand names,
Tofranil, Base
Analogs
Tofranil, Base
Brand Names Mixture
Tofranil, Base
Chemical_Formula
C19H24N2
Tofranil, Base
RX_link
http://www.rxlist.com/cgi/generic/imip.htm
Tofranil, Base
fda sheet
Tofranil, Base
msds (material safety sheet)
Tofranil, Base
Synthesis Reference
No information avaliable
Tofranil, Base
Molecular Weight
280.407 g/mol
Tofranil, Base
Melting Point
174.5 oC
Tofranil, Base
H2O Solubility
18.2 mg/L
Tofranil, Base
State
Solid
Tofranil, Base
LogP
4.184
Tofranil, Base
Dosage Forms
Tablet
Tofranil, Base
Indication
For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older.
Tofranil, Base
Pharmacology
Imipramine is a tricyclic antidepressant with general pharmacological properties similar to those of structurally related tricyclic antidepressant drugs such as amitriptyline and doxepin. A tertiary amine, imipramine inhibits the reuptake of serotonin more so than most secondary amine tricyclics, meaning that it blocks the reuptake of neurotransmitters serotonin and noradrenaline almost equally. It is also effective in migraine prophylaxis, but not in abortion of acute migraine attack.
Tofranil, Base
Absorption
Rapidly and well absorbed after oral administration
Tofranil, Base
side effects and Toxicity
Oral, rat LD50: 355 to 682 mg/kg. Toxic signs proceed progressively from depression, irregular respiration and ataxia to convulsions and death.
Tofranil, Base
Patient Information
Tofranil, Base
Organisms Affected
Humans and other mammals